Paper
Document
Download
Flag content
0

Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetinib (TACo) in patients (pts) with PD1 refractory metastatic brain metastases (MBM)

0
TipTip
Save
Document
Download
Flag content